Skip to main content
. 2017 Nov 4;53(6):725–739. doi: 10.1007/s00535-017-1408-0

Table 1.

Expression of miR-324-3p in human gastric cancer and the clinicopathological characteristics of the patients

Characteristics Number (%) miR-324-3p expression P value Smad4 expression P value
High group Low group High group Low group
Age (years)
 ≥ 60 43 (63.2%) 23 20 0.451 21 22 0.801
 < 60 25 (36.8%) 11 14 13 12
Gender
 Male 37 (54.4%) 18 19 0.808 20 17 0.465
 Female 31 (45.6%) 16 15 14 17
Size (cm)
 ≥ 3 (cm) 36 (52.9%) 23 13 0.015* 12 24 0.004*
 < 3 (cm) 32 (47.1%) 11 21 22 10
Stages
 I/II 30 (44.1%) 14 16 0.625 18 12 0.143
 III/IV 38 (55.9%) 20 18 16 22
T grade
 T1 + T2 38 (55.9%) 17 21 0.329 20 18 0.625
 T3 + T4 30 (44.1%) 17 13 14 16
Lymph node metastasis
 N1–N3 40 (58.8%) 22 18 0.324 17 23 0.139
 N0 28 (41.1%) 12 16 17 11
Lauren classification
 Intestinal type 30 (44.1%) 12 18 0.330 19 11 0.094
 Diffuse type 27 (39.7%) 16 11 12 15
 Mixed type 11 (16.2%) 6 5 3 8

*P < 0.05 statistically significant difference